COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)

BackgroundBy 2023, COVID-19 had caused 6.8 million deaths in the United States. COVID-19 presents more severely in leukemia compared to solid tumors (OR 1.6, p<0.05). However, data on Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) are limited. We investigated the mortality in AML...

Полное описание

Библиографические подробности

Главные авторы:	Barath Prashanth Sivasubramanian, Shashvat Joshi, Diviya Bharathi Ravikumar, Madhumithaa Jagannathan, Sonia Babu, Shanthi Reddy Sripathi, Avinash Javvaji, Priyanshu Jain, Dinesh Kumar Shanmugam, Bharath Duraisamy Swami Kannan, Raghavendra Tirupathi, Rutul Dalal
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2024-10-01
Серии:	Frontiers in Oncology
Предметы:	AML myelodysplastic syndrome COVID-19 severe sepsis ARDS acute respiratory failure
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1446482/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!